CORC

在结果中检索

CORC

浏览/检索结果: 共218条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Doxorubicin hydrochloride enhanced antitumour effect of CEA-regulated oncolytic virotherapy in live cancer cells and a mouse model 期刊论文
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020
作者:  Xiao, Boduan;  Ying, Chang;  Chen, Yongyi;  Huang, Fang;  Wang, Binrong
收藏  |  浏览/下载：31/0  |  提交时间：2020/11/30
The development of a cell-based model for the assessment of carcinogenic potential upon long-term PM2.5 exposure 期刊论文
ENVIRONMENT INTERNATIONAL, 2019, 卷号: 131, 页码: 13
作者:  Chen, Shen;  Li, Daochuan;  Zhang, Haiyan;  Yu, Dianke;  Chen, Rui
收藏  |  浏览/下载：26/0  |  提交时间：2020/04/27
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO SEVERE PATIENTS WITH RHEUMATOID ARTHRITIS 期刊论文
ANNALS OF THE RHEUMATIC DISEASES, 2019, 卷号: 78
作者:  Qiu, Wenting;  Chai, Katherine;  Guo, Xinjun;  Zhang, Xin;  Liu, Eugene
收藏  |  浏览/下载：60/0  |  提交时间：2019/12/04
Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis 期刊论文
CELL, 2019, 卷号: 176, 期号: 5
作者:  Yin, Chengqian;  Zhu, Bo;  Zhang, Ting;  Liu, Tongzheng;  Chen, Shuyang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis 期刊论文
CELL, 2019, 卷号: 176, 期号: 5
作者:  Yin, Chengqian;  Zhu, Bo;  Zhang, Ting;  Liu, Tongzheng;  Chen, Shuyang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis 期刊论文
Cell, 2019, 卷号: 176, 页码: 1113-1127.e16
作者:  Yin Chengqian[1];  Zhu Bo[2];  Zhang Ting[3];  Liu Tongzheng[4];  Chen Shuyang[5]
收藏  |  浏览/下载：57/0  |  提交时间：2019/04/22
Establishment of highly sensitive analytical method for chondroitin sulfate by flow injection chemiluminescence 期刊论文
CARBOHYDRATE POLYMERS, 2019, 卷号: 206, 页码: 504-510
作者:  Zhang, Siying;  Zhou, Guanglian;  Zhang, Xiao;  Chen, Dong;  Liu, Jian
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Zeng, Xiaofeng;  Wang, Yongfu;  Jiang, Zhenyu;  Zhang, Zhuoli;  He, Lan
收藏  |  浏览/下载：46/0  |  提交时间：2020/01/03
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO 期刊论文
2019, 卷号: 78, 页码: 1140-1140
作者:  Zeng, Xiaofeng;  Wang, Yongfu;  Jiang, Zhenyu;  Zhang, Zhuoli;  He, Lan
收藏  |  浏览/下载：42/0  |  提交时间：2020/01/03
Topographical patterning: characteristics of current processing techniques, controllable effects on material properties and co-cultured cell fate, updated applications in tissue engineering, and improvement strategies 期刊论文
Journal of materials chemistry. B, 2019
作者:  Zhang Ke;  Xiao Xiongfu;  Wang Xiumei;  Fan Yubo;  Li Xiaoming
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/30

©版权所有 ©2017 CSpace - Powered by CSpace